<DOC>
	<DOC>NCT00002282</DOC>
	<brief_summary>To compare the efficacy, safety, and tolerance of fluconazole single daily capsule for 14 days versus clotrimazole troche 5 x daily for 14 days in the treatment of oropharyngeal candidiasis in patients with AIDS.</brief_summary>
	<brief_title>A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis, Oral</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication: Allowed: Cimetidine. Exclusion Criteria Coexisting Condition: Patients with the following are excluded: Known history of intolerance or allergy to imidazoles or triazoles, or the nonazole components of clotrimazole troches (dextrose, cellulose, povidone, magnesium stearate). Moderate or severe liver disease defined by specified lab values. Concurrent Medication: Excluded pending results of phase I studies to determine whether interaction between fluconazole and these agents occurs: Barbiturates. Phenytoin. Coumarintype anticoagulants. Rifampin. Oral hypoglycemics. Cyclosporin. Patients with the following are excluded: Known history of intolerance or allergy to imidazoles or triazoles, or the nonazole components of clotrimazole troches (dextrose, cellulose, povidone, magnesium stearate). Unable to tolerate oral medication. Moderate or severe liver disease defined by specified lab values. Life expectancy &lt; 4 weeks. Unable or unwilling to be followed at the same center for the conduct of this study. Prior Medication: Excluded within 3 days of study entry: Other antifungal agents. Excluded pending results of phase I studies to determine whether interaction between fluconazole and these agents occurs: Barbiturates. Phenytoin. Coumarintype anticoagulants. Rifampin. Oral hypoglycemics. Cyclosporin. Patients meeting CDC criteria for diagnosis of AIDS, or having serologic or virologic evidence of HIV infection (but without AIDSdefining opportunistic infections as of yet). Patients who have given informed consent in writing to their participation in the study. Patients with signs of oropharyngeal candidiasis, i.e., with typical white plaques.</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 1990</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Fluconazole</keyword>
	<keyword>Clotrimazole</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Candidiasis, Oral</keyword>
</DOC>